Super-Resolution Ultrasound for Lymph Node Evaluation: Diagnostic Value of Static Time-Point Parameters Versus Dynamic Temporal Changes
Related Experiment Video
Updated: Nov 3, 2026

High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes
Published on: July 25, 2015
Qing Xie1, Ruixue Cui1, Zhendan Zhao1
1Department of Ultrasound, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Objectives:
To evaluate quantitative super-resolution ultrasound (SRUS) parameters (static central-to-peripheral ratios and dynamic temporal changes) for differentiating benign and metastatic lymph nodes, and to compare the performance of corresponding predictive models.
Methods:
A prospective study included 172 pathologically confirmed lymph nodes (100 benign, 72 metastatic). SRUS was performed to derive density and velocity parameters, with central-to-peripheral ratios and temporal changes calculated. Static and dynamic models were constructed using univariate analysis, least absolute shrinkage and selection operator (LASSO), and logistic regression. Model performance was assessed by cross-validation, area under the receiver operating characteristic curve (AUC), calibration, decision curve analysis, and clinical impact curve.
Results:
Metastatic lymph nodes showed significantly lower central-to-peripheral ratios of density and velocity parameters but higher relative temporal changes in density SD and velocity SD compared with benign nodes (all P < .05). The static time-point model retained 2 SRUS variables (Mean.Density_C_P_T2, Max.Density_C_P_T3), yielding a full-sample AUC of 0.8607. The temporal change model included 2 dynamic parameters (Velocity SD change from T1 to T2, Mean density change from T2 to T3) and achieved a higher AUC of 0.8715, with better accuracy, specificity, and model fit. Both models showed favorable calibration and clinical net benefit.
Conclusion:
Quantitative SRUS parameters effectively reflect pathological angiogenesis in metastatic lymph nodes. The temporal change model provides superior diagnostic performance over the static time-point model and may serve as a reliable noninvasive tool for distinguishing benign from metastatic lymph nodes.